News
$VYNE Therapeutics (VYNE.US)$ Vyne Therapeutics Announces Granting of Composition of Matter Patent for Vyn202, a Novel BD2-Selective Bet Inhibitor! Has 20 year term
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
重庆空投军 : Can I add it??
Trytosaveabit OP 重庆空投军 : I don’t give buy/sell advice because I have no way to know others risk tolerance or the type of trade they are doing! Hope you understand? GL